Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2026 16:05 ET | Source: Insight Molecular Diagnostics Inc.

IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results

Submitted GraftAssureDx™ for kidney transplant rejection testing for FDA review on Wednesday, March 25Welcomed second favorable head-to-head data set from an independent study at large hospital...
March 26, 2026 16:05 ET | Source: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Reports Full Year 2025 Financial Results and Operational Updates

On track for DENALI Part 2a dose confirmation in 1H 2026DENALI Part 2 trial topline readout expected by year end 2026; potential to support accelerated approvalOn track to initiate the ASPENOVA Phase...
March 26, 2026 09:49 ET | Source: Viper Networks, Inc.

Viper Networks Subsidiary 0Wire Communications Joins the Caribbean Datacenter Association (CDA)

TROY, Mich. and WILLEMSTAD, Curaçao, March 26, 2026 (GLOBE NEWSWIRE) -- Viper Networks (OTCID: VPER) subsidiary 0Wire Communications has joined the Caribbean Datacenter Association as an...
March 26, 2026 08:10 ET | Source: Coinup

CoinUp Reports Strong Half-Year Growth Across Key Metrics

CoinUp Reports Strong Half-Year Growth Across Key Metrics
March 26, 2026 08:00 ET | Source: MeiraGTx

MeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiation-Induced Xerostomia (RIX) and Reports Fourth Quarter and Full Year 2025 Financial and Operational Results

FDA granted Breakthrough Therapy Designation for AAV2-hAQP1 for the treatment of Grade 2 and Grade 3 late xerostomia caused by radiotherapy for cancers of the upper aerodigestive tractMeiraGTx to hold...